LHCH Cath Labs are first in the north of England to use new ablation technology
On Friday, our Cath Lab team carried out the first procedures here at LHCH using a new exciting, pulsed field ablation technology. LHCH is the first hospital in the north of England providing this technology to benefit our patients with atrial fibrillation. Atrial Fibrillation is an irregular and often very rapid heart rhythm which can make your heartbeat too quickly and in an irregular way.
The Affera™ Sphere-9 Mapping and Ablation Sphere-9™ Catheter is an innovative technology for the treatment of cardiac arrhythmias, including both Radiofrequency and Pulsed Field ablation options in one catheter and all-in-one mapping with excellent safety and effectiveness data already demonstrated*. 1 2 3 4
Dr Vishal Luther, Consultant Cardiologist & Electrophysiologist spoke of the new technology:
“As a centre of excellence, we were pleased to be given the opportunity to experience this innovative new ablation system for the first time at LHCH. The benefits of the new system, for patients and staff, includes shorter, seamless procedures and faster recovery times. Thank you to the multi-disciplinary team involved in the successful installation of the new technology and completion of the first procedures. We are delighted with the patient outcomes and results!”
*Evidence has showed 0.6% device-related primary adverse events using RF or PF energy, 97% durable lesions per-vein durability at 3 months, and an average time to complete a pre-ablation map of 11 mapping minutes
1 Reddy, Vivek Y., et al. “Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial.” Circulation: Arrhythmia and Electrophysiology 13.6 (2020): e008718.Study.
2 Reddy, Vivek Y., et al. “B-PO01-055 ATRIAL FIBRILLATION ABLATION USING A FOCAL LATTICE-TIP CATHETER THAT TOGGLES BETWEEN PULSED FIELD AND RADIOFREQUENCY ENERGY: EFFECT ON THE ESOPHAGUS.” Heart Rhythm 18.8 (2021): S73 4 Confirm Rx ICM K182981 FDA Clearance Letter. 2019.
3 CR-00014 Rev C. Medtronic data on file.
4 Reddy, Vivek Y., et al. “A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation.” JACC: Clinical Electrophysiology (2023): In press.